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A B S T R A C T
Telomeres are a repeated sequence -of bases found at the ends of chromosomes. In humans, this sequence is
TTAGGG, which is repeated over 2000 times. Telomeres protect the ends chromosomes from fusion with nearby
chromosomes, and allow effective replication of DNA. Each time a cell divides, 25–200 base pairs are lost from
the terminal sequence of chromosomes. By becoming truncated during cell division, telomeres protect essential
genes from being shortened and thus inactivated. In addition, telomeres are sensitive to inflammation and
oxidative stress, which can further promote telomere shortening. Reduction in the length of telomeres leads to
the cessation of cell division and thus cellular senescence and apoptosis. This review discusses evidence for the
role of oxidative stress and inflammation in regulating the length of telomeres in mammalian cells during
senescence. Evidence is presented suggesting that antioxidants and anti-inflammatories can reduce the pace of
shortening of telomere length during aging. The distinctive properties of transformed cells suggest that treatment
with such materials will have a deleterious rather than a protective effect on such abnormal cells.
1. Introduction
Ageing can be defined as a gradual deterioration of organ function
toward the end of the life span. Environmental-, dietary-, lifestyle-
related factors, and heritable gene mutation can all contribute to the
individual rate of aging. Levels of oxidative stress, inflammation,
mitochondrial dysfunction, antioxidants, shortening of telomeres and
gene mutations are all likely to play a role in determining the pace of
cellular aging. There is considerable evidence to show that reduction in
the length of telomeres is associated with failure of cell division and
senescence of normal cells, and that oxidative stress and inflammation
can contribute to the rate of attrition of telomere length. These studies
are discussed in this manuscript together with some suggestions as to
how aging events may be beneficially influenced by exogenous factors.
Telomeres consist of a repetitive sequences of TTAGGG located at
the end of chromosome needed for the replication of DNA. Telomerase
reverse transcriptase (TRT) is the catalytic subunit of telomerase
enzyme that is responsible for maintaining telomere length by adding
telomere repeats TTAGGG at the end. On the other hand, telomeric
repeat-binding factor-2 (TRF-2) is needed for the telomere mainte-
nance, cell cycle progression, and protection of the ends to avoid
chromosomal fusion (Hanaoka et al., 2005; Kim et al., 2009).
One of the widely held hypotheses is that aging of mammalian cells
is due to shortening of telomere length (Mikhelson and Gamaley, 2012).
This is supported by the fact that point mutations within the telomere
cause accelerated attrition of telomere length and also lead to pre-
mature aging (Fyhrquist and Saijonmaa, 2012). There is substantial
evidence to show that increased oxidative stress and inflammation play
a central role in shortening the length of telomeres possibly by
decreasing the activity of telomerase and/or TRF-2 level.
The length of telomeres is maintained in cancer cells despite
increased oxidative stress and inflammation (Ennour-Idrissi et al.,
2016; Bertorelle et al., 2014; Rode et al., 2016). Telomerase is
expressed in over 95% of cancer types, at a much higher levels than
in normal adult tissues. This is due to the reactivation of the gene
hTERT, which is generally silent in adult tissues, leading to production
of telomerase reverse transcriptase, TERT (Bermudez et al., 2007), and
reappearance of active telomerase ribonucleoprotein. Inhibition of
oxidative stress protects telomerase activity in normal cells but inhibits
that in tumor cells. This apparent contradiction has been accounted for
by the higher redox homeostasis threshold that exists in cancer cells
causing them to have a high demand for reactive oxygen species (ROS),
(Li et al., 2016a).
This review discusses the role of oxidative stress and inflammation
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in regulating the length of telomeres in mammalian cells. In addition, it
presents evidence to show that antioxidant and anti-inflammatory
agents may reduce the pace aging by curtailing the rate of shortening
of telomere length. It should be emphasized that, in view of the large
overlap between oxidant and inflammatory events the distinction
between protective agents acting on either, is rather arbitrary.
2. Effects of oxidative stress on telomere length
Evidence from a variety of human studies that show oxidative status
and telomere length are closely related. These studies are enumerated
here.
2.1. Clinical reports
Several clinical reports illustrate the link between pro-oxidant
events and telomere status.
2.1.1. Periodontitis
Increased oxidative stress and inflammation is associated with
reduced leukocyte telomere length in patients with periodontitis
(Masi et al., 2011).
2.1.2. Parkinson’s disease
Enhanced oxidative stress is found in patients with Parkinson’s
disease and that shortened length of telomeres in the blood cells is
associated with this disease (Watfa et al., 2011).
2.1.3. Depression
Gene expression of oxidative defense enzymes superoxide dismu-
tases (SOD1 and SOD2), catalase (CAT) and glutathione peroxidase
(GPX1) were significantly lower in oligodendrocytes derived post-
mortem from patients suffering from major depressive disorders. This
was accompanied by a reduction of both telomeric length and levels of
TERT in oligodendrocytes but not astrocytes (Szebeni et al., 2014).
2.1.4. Diabetes
Increased oxidative stress together with shortened length of leuko-
cyte telomeres is found in type 1 and type 2 diabetes. In addition, older
people with central obesity, hyperglycemia, insulin resistance and
lower antioxidant levels had shorter leukocyte telomere length (Ma
et al., 2013). The monocyte telomere shortening observed in type 2
diabetes could be due to increased oxidative DNA damage to monocyte
precursors during cell division (Sampson et al., 2006).
2.1.5. Aging
Elderly men living in Greece have lower indices of oxidative stress
and higher antioxidant levels, than a corresponding population of
elderly Dutch men, living in a more stressful urban setting and a diet
less rich in antioxidant nutrients. The length of telomeres in leukocytes
was significantly greater in the Greek relative to the Dutch population
(De Vos-Houben et al., 2012). This suggests causal relationship between
increased oxidative stress and shortening of the telomere length during
aging.
2.1.6. Twin study
In a metabolomics study of over 300 adult twins, there was a
relation between indices of oxidative stress, decline in organ function
and reduced leukocyte telomere length (Zierer et al., 2016). While this
does not imply causality, such a correlation supports findings from
studies involving more defined studies using in vitro systems
2.1.7. Dyskeratosis congenita
Dyskeratosis congenita (DC) is a multi-system disorder character-
ized by defects of the skin, nails, and mucous membrane. Most cases are
also associated with bone marrow dysfunction. This disease exhibits
severe telomere abnormalities attributable to defects in six genes
coding for those proteins, such as TERC and TERT responsible for
maintaining telomere length (Kirwan and Dokal, 2009).
2.2. Isolated systems
Findings directly paralleling the human studies described above
have also been obtained in isolated cell systems. Some examples:
Increased oxidative stress induced by treatment with H2O2 shor-
tened the length of telomeres isolated in mouse skeletal muscle fibers
(Ludlow et al., 2014).
Enhanced oxidative stress induced by treatment with tert-butyl
hydroperoxide or L-buthionine-(S, R)-sulphoximine shortened the
length of telomeres and caused senescence in human endothelial cells
(Kurz et al., 2004).
Mild hyperoxia reduced the length of telomeres and induced
senescence in human fibroblasts (von Zglinicki et al., 1995).
While it is clear that oxidative events can lead to telomere short-
ening, it is not fully established whether this is due to inhibition of
TERT and/or TRF2. Additional studies on effects of ROS donors on
telomere length in normal cell models as well as animal models of aging
are needed to identify the mechanisms underlying such events.
2.3. Immune system
The cells of the immune system are very sensitive to shortening of
telomere length, since the competency of immune system depends upon
cell renewal and clonal expansion of T-and B-lymphocytes. These cells
can increase the activity of telomerase and thereby limit telomere
attrition in cells undergoing active proliferation. Oxidative stress is one
of the factors that induce senescence in immune cells (Kaszubowska,
2008). In many cell types from patients with coronary heart disease
(leukocytes, CD34+ peripheral blood stem cells and progenitor cells,
monocytes, granulocytes, B-lymphocytes, and CD4+ T lymphocytes),
the length of telomeres was shorter than in their age-matched control
subjects. Shortening of telomere length was the most pronounced in
cytotoxic CD8 T lymphocytes (Spyridopoulos et al., 2009). The same
study reported that cytomegalovirus infection in CD8+CD28 (−) T
cells caused further shortening of telomere length. T cell senescence
occurs prematurely in patients with rheumatoid arthritis. The low levels
of the DNA double-strand break repair nuclease MRE11A caused
damage to telomeres and induced senescence in rheumatoid arthritis
t-lymphocytes. Inhibition of the activity of MRE11A in healthy T cells
induced senescence, whereas overexpression of MRE11A in T cells from
patients with rheumatoid arthritis reversed these cells to normal
phenotypes (Li et al., 2016b). Thus the length of telomeres in T cells
depends upon the activity of MRE11A. In the CD3+T-cells from
patients with myelodysplastic syndrome (MDS), the high rate of
attrition of telomere length occurs because of lower telomerase activity
as well as reduced expression of telomere reverse transcriptase mRNA
(Yang et al., 2013).
3. Effects of inflammation on telomere length
Some examples of the intimate relation between inflammatory
events and telomeric length are listed:
3.1. Obesity
Obesity is associated with enhanced oxidative stress and inflamma-
tion (Hulsegge et al., 2016; Zhao et al., 2016). Weight gain during
adulthood and obesity contribute to shorter leukocyte telomere length
in adults younger than 60 years of age (Muezzinler et al., 2016). Higher
Body Mass Index (BMI) and obesity at the age of 25 can lead to a
reduced length of leukocyte telomeres (Wulaningsih et al., 2016).
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3.2. Caloric restriction
A causal relationship between metabolic signs of inflammation and
telomere shortening is suggested by the finding that caloric restriction
prevented decline in leukocyte telomere length, whereas a high intake
of omega-6 fatty acids with pro-inflammatory activity increased the
rate of loss of length of leukocyte telomeres (Kark et al., 2012). Caloric
restriction also improves cardiac function in diabetic mice and this is
accompanied by increased telomerase activity (Makino et al., 2015).
Another study reported that pro-inflammatory diet causes acceler-
ated rate of attrition of leukocyte telomere length compared to that
found with anti-inflammatory diet (Garcia-Calzon et al., 2015b).
3.3. Inflammation
Increased serum homocysteine levels together with elevated inflam-
mation has been found to be associated with reduced length of
leukocyte telomeres in adults 55 years or older (Shin and Baik,
2016). Populations of the elderly (85–99 years of age), and centenar-
ians (100–104 years old), maintained long telomeres and low levels of
basal inflammation. The offspring of centenarians expressed similarly
long telomeres and reduced basal inflammatory activity relative to age
matched controls (Arai et al., 2015). However, low levels of inflamma-
tion were found to be better predictors of healthy aging than telomere
length (Arai et al., 2015). In a separate study, supercentenarians
(105–109 years old) were found to have significant shorter leukocyte
telomeres than centenarians (100–104 years old), suggesting progres-
sive attrition of telomeres after the age of 104 years (Tedone et al.,
2014). Hyperactivity of the transcriptional factor NF-kB and enhanced
expression of pro-inflammatory cytokines, such as TNF-alpha, IL-6, and
IFN-gamma in circulating macrophages, contribute to the shortening of
telomeres and the onset of senescence (Zhang et al., 2016).
3.4. Reciprocity of inflammation and telomerase
Mutations in human telomerase RNA component (TERC) and
telomerase reverse transcriptase (TERT) increased the levels of pro-
inflammatory cytokines in the lung and caused premature aging in
alveolar stem cells (Chen et al., 2015). These results are important in
that they indicate that the relationship between impaired telomeres and
inflammation may be reciprocal. Thus, aging may involve interplay of
inflammatory events and telomeric dysfunction.
3.5. Mechanisms of action of oxidative stress and inflammation on telomere
length
The mechanisms of oxidative stress-induced shortening of the length
of telomere are not fully understood. Oxidative stress can impair
endonuclease III-like protein 1 (Nth1) protein responsible for the repair
oxidative DNA damage leading to the loss of telomere length
(Vallabhaneni et al., 2013). Oxidative stress causes a decline in the
ability of DNA to repair oxidative damage that results in shortening of
telomeres during aging (Duan et al., 2005). Deficiency of the nucleotide
excision repair pathway renders cells more sensitive to oxidative stress
causing increased telomere attrition (Ting et al., 2010). Oxidative stress
increases the expression of phosphorylated cyclin-dependent kinase
inhibitor p16 (INK4a) and this induces senescence in endothelial
progenitor cells (EPCs) associated with shortening of telomere length
(Yang et al., 2008). Increased oxidative stress may enhance the
expression of miR-195 that inhibits SIRT1 leading to senescence
associated with shortening of telomeres (Kondo et al., 2016). Increased
oxidative stress as well as pro-inflammatory cytokines, also upregulate
the expression of miR-146a (Jiao et al., 2015; Pogue et al., 2011).
Increased expression of miR-146 was found in senescent human
umbilical vein endothelial cells (HUVECs) (Olivieri et al., 2013). Taken
together, these studies suggest that oxidative stress and inflammation
may shorten telomere length by upregulating the expression of miR-
146.
4. Influence of antioxidants on telomere length
Several reports indicate that antioxidants can reduce the velocity of
telomeric shortening:
4.1. Carotenoids
In a study of over 3000 US adults, increased serum levels of
carotenoids were significantly associated with longer leukocyte telo-
meres. It was suggested that high intake of carotenoid-rich food may
play a role in protecting telomeres against oxidative damage (Min and
Min, 2016).
4.2. Cardiac disease
Using endothelial cells (EC) isolated from arterial segments of
patients with severe coronary artery disease, treatment with n-acet-
ylcysteine (NAC) reduced the rate of shortening of telomeres, but did
not significantly delayed the onset of senescence (Voghel et al., 2008).
In contrast, normal endothelial cells in culture show gradual senescence
together with increased production of ROS and mitochondrial dysfunc-
tion. In addition, telomerase reverse transcription (TERT) is translo-
cated from the nucleus to the cytoplasm leading to Src-kinase activa-
tion. Treatment of these cells with NAC prevented these changes and
delayed senescence (Haendeler et al., 2004). Endothelial cells from
heart disease patients are already damaged; and may respond to NAC
differently from the normal endothelial cells.
4.3. Diet
Diet seems to be a significant factor in determining telomere status.
Several human clinical reports exist suggesting the beneficial effects of
antioxidants in the diet, on telomere function. Mechanistic under-
standing of events underlying these reports, is complicated by the
simultaneous presence of more than one anti-oxidant. However, such a
multiplicity of compounds reflects a more typical condition and may
provide benefits due to unanticipated synergies.
In children and adolescents, longer telomere length in leukocytes
has been related to a diet rich in antioxidants, while diets rich in white
bread were associated with shorter telomeres (Garcia-Calzon et al.,
2015a).
In men and women, ages 40–85, supplementation with omega-3
fatty acids, thereby decreasing the ratio of dietary omega-6:omega-3
fatty acids, reduced oxidative stress, and increased the length of
telomeres (Kiecolt-Glaser et al., 2013). Since omega-6 fatty acids
exhibit pro-inflammatory activity, whereas omega-3 fatty acids show
anti-inflammatory activity, decreasing this ratio would decrease the
proportion of pro-inflammatory cytokines and thus reduce the rate of
attrition of telomere length. A diet rich in monounsaturated fatty acids
such as in the olive oil of the Mediterranean diet, can retard leukocyte
telomere length attrition, (Gomez-Delgado et al., 2016).
In healthy Japanese adults, elevated levels of beta-carotene and
alpha tocopherol protected buccal mucosal cell from telomere short-
ening (Yabuta et al., 2016). In an Australian stroke prevention study
population (average age 66 years), enhanced plasma concentrations of
lutein, zeaxanthin, and vitamin C were associated with longer leukocyte
telomeres (Sen et al., 2014).
A human population aged 35–55, received dietary supplementation
with a commercial preparation of multivitamins containing omega-3-
fatty acid, carotenoids, coenzyme Q10, selenium, vitamin D and alpha-
tocopherol for 12 weeks, increased the activity of lymphocytic telomer-
ase without affecting the length of telomeres (Balcerczyk et al., 2014).
This report found that antioxidant treatment improved several anti-
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aging indices without changing the length of lymphocyte telomeres.
These results might suggest that shortening the length of telomeres may
not be associated with aging. However, some observations in this study
are conflicting. For example, that antioxidant treatment increased the
activity telomerase without affecting the length of telomeres that
appears to be inconsistent. It may be that the improvement of several
indices of aging without changing telomere length may be a reflection
of complex multi-factorial nature of the aging process.
4.4. Antioxidant treatment in isolated cells, or animals
Many studies using animal models or isolated cell lines corroborate
the human reports described above. Some examples:
Heart/muscle-specific manganese superoxide SOD-deficient mice
(H/M-SOD2 -/) are characterized by dilation of the end-diastolic
dimension, inhibition of telomerase activity, reduction of the levels of
TERT, and telomere repeat-binding factor-2 (TRF-2) proteins.
Administration of EUK-8, a superoxide dismutase (SOD) and catalase
mimetic in SOD-deficient mice prevented tall of these changes in the
heart tissue (Makino et al., 2011).
Reduced length of telomere and activity of telomerase together with
evidence of DNA damage were found in human diploid fibroblasts after
repeated cell passages. Treatment of fibroblasts with tocotrienol-rich
fraction prevented senescence by restoring telomere length and telo-
merase activity (Makpol et al., 2011).
Vitamin E suppressed endogenous telomerase activity in ovarian
cancer cells, but has no effects on telomerase-negative normal ovarian
surface epithelial cells (Bermudez et al., 2007). This is another example,
repeatedly described in this review, of the opposite effect of antioxidant
or anti-inflammatory agents, on atypical cells as opposed to normal
cells.
5. Influence of anti-inflammatory agents on telomeres
In a manner analogous to the properties of anti-oxidants, several
agents whose qualities include anti-inflammatory properties, appear
able to influence telomerase activity and hTERT expression:
5.1. Resveratrol
There are numerous reports of the ability of resveratrol to con-
tribute toward the maintenance of telomere length. Orally administered
resveratrol fed to old mice can reverse age related changes in ovarian
telomerase activity, telomere length and age-related gene expression,
resulting in the profile of these parameters to resemble those of young
mice rather than control untreated old animals (Liu et al., 2013). In an
isolated culture system, resveratrol can enhance telomerase activity of
endothelial progenitor cells and thereby delay their senescence (Wang
et al., 2011). This in vitro effect suggests that resveratrol can act
directly on cells rather than its abilities being mediated by systemic
changes. Resveratrol is known to enhance levels of anti-inflammatory
microRNAs, while repressing pro-inflammatory microRNAs (Latruffe
et al., 2015). Thus the mechanism of protection of telomeres may in
part be mediated by microRNAs.
5.2. Curcuminoids
Curcuminoids are also able to enhance telomerase activity assayed
by telomere repeat amplification protocol (TRAP), in a cell free system,
(Taka et al., 2014). This implies a direct effect on telomerase not
involving the immune system. An interesting paradox, reflecting that
found in the case of anti-oxidants involves the responses of malignant
cells to curcumin. In T47D cells a breast cancer line, curcumin exerted
cytotoxic effects and inhibited telomerase gene expression (Nasiri et al.,
2013). Another example of this paradoxical effect of curcumin on
transformed cells, is the report that curcumin inhibits telomerase and
down-regulates hTERT mRNA in glioblastoma and medulloblastoma
cells (Khaw et al., 2013).
5.3. Aspirin
Aspirin is the archetype of anti-inflammatory drugs and has also
been found to stimulate telomerase activity in normal bone marrow
mesenchymal stem cells leading to improvement in their immunomo-
dulatory capacity (Chen et al., 2014). Once again, the effect of aspirin
on malignant cell lines is the opposite of responses elicited from normal
cells. The telomerase activity in several cell types isolated from colon
carcinoma, is inhibited (He et al., 2006). Since this occurs together with
reduced levels of hTERT mRNA, a direct effect on gene expression is
indicated. Aspirin, also inhibits the telomerase activity of a non-
malignant but pathological cell type. This is the polymorphonuclear
neutrophil derived from carotid plaques (Li et al., 2013). Thus it seems
that any cells with sufficiently abnormal metabolism respond to anti-
inflammatory agents in a manner opposite to that of normal cells.
5.4. Catechins
Another class of compounds expressing the same ambivalence
toward cells of malignant origin in contrast to normal cells, are the
catechin polyphenols found in green tea. This class of compound
prevents shortening of telomere length and cardiac myopathy in
manganese superoxide dismutase deficient mice (Oyama et al., 2017),
but inhibits TERT expression in human breast cancer cells (Meeran
et al., 2011). Similarly, in a transformed cell line, both mRNA of hTERT
and telomerase were decreased after treatment with epigallocatechin
gallate (Wang and Lei, 2015). Cardiac hypertrophy initiated by a
pressure overload leads to loss of TRF-2, and progressive loss of
telomeres and apoptosis in rat heart myocardium. Treatment of rats
with epigallocatechin, the major component of green tea, and quercetin
prevented such changes (Sheng et al., 2013).
5.5. Statins
Other drugs whose properties contain a significant anti-inflamma-
tory component, are the statins. Several reports of their ability to
promote telomerase activity exist, including human trials (Janić et al.,
2016). It has been proposed that the chronic inflammation associated
with aging and many disorders, plays a role in facilitating telomere
shortening and that statins can ameliorate this (Kordinas et al., 2016).
Since inflammation involves increases in oxidative events, these process
are obviously closely linked and it has been proposed that anti-aging
effects of statins involve inhibition of telomere shortening by either
direct or indirect reduction of oxidative damage to telomeric DNA
(Olivieri et al., 2012).
5.6. Stress
Exposure to psychosocial stress has been associated with increased
oxidative stress and inflammation (Maes et al., 2011; Maes, 2013;
Wilson et al., 2013). Children exposed to stressful life events had
shorter leukocyte telomeres upon reaching middle-age (Osler et al.,
2016). Adults exposed to psychosocial stress have similarly reduced
length of leukocyte telomeres (van Ockenburg et al., 2015). However,
there are also conflicting reports in this area. Telomerase activity in
stressed rats was elevated by 54% (Beery et al., 2012). The effect of
stress on increasing levels of telomerase has been replicated in a human
trial involving exposing both dementia patients and their caregivers to
acute psychological stress (Epel et al., 2010). Since stress elevates levels
of cortisol and this results in depressed immune function, this suggests
that inflammatory activity can translate into telomere shortening. It
seems that the telomeric response to stress is biphasic. Beneficial at the
levels of a transient healthy challenge, but harmful if excessively
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prolonged when factors other than cortisol levels may come into play.
6. Conclusion
Overall, these studies from isolated systems and human populations
all point to a causal link between inflammation and oxidative stress as
determinants of telomere integrity. How the processes underlying such
links occur and how the microRNAs interact with these events, are all
not well understood and more investigations on effects of pro-inflam-
matory cytokines on telomere length in normal cell models as well as
animal models of aging are needed to support the idea that aging
involves interplay between inflammation and telomeric dysfunction.
The studies discussed in this review suggest the possibility of ther-
apeutic interventions to retard cellular aging and thereby reduce the
incidence of age-associated diseases. Since transformed or otherwise
abnormal cell types appear to respond to anti-oxidants and anti-
inflammatory agents in a manner opposite to normal tissues, consump-
tion of these exogenous materials seems to exclusively benefit cells of
non-pathological origin. While the reasons underlying this major
difference are not well understood, the application of dietary micro-
nutrients one of the safest approaches toward optimal aging and
increased longevity. This could include anti-oxidant and anti-inflam-
matory agents including targeted dietary modifications or scientifically
designed mixtures (Prasad and Bondy, 2014).
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